Hyperfine (HYPR)
(Delayed Data from NSDQ)
$1.03 USD
-0.03 (-2.83%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.05 +0.02 (1.94%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HYPR 1.03 -0.03(-2.83%)
Will HYPR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HYPR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HYPR
Hyperfine Stock Rises After FDA Clears Next-Gen Swoop MRI System
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates
HYPR: What are Zacks experts saying now?
Zacks Private Portfolio Services
TransMedics (TMDX) Tops Q1 Earnings and Revenue Estimates
HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
Other News for HYPR
Hyperfine (HYPR) Begins Patient Enrollment for AI-Powered MRI Study
Hyperfine enrolls first patient in PRIME study
Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of ...
Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025 | HYPR ...